Source:http://linkedlifedata.com/resource/pubmed/id/17951197
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-10-22
|
pubmed:abstractText |
We assessed the expression of vascular endothelial growth factors (VEGF-C and VEGF-D) in breast cancer cells and the density of lymph vessels and VEGF receptor-3 (VEGFR-3)-positive vessels in and around the tumor in invasive lobular breast cancer. We found significant correlation between peritumoral lymph vessel density and presence of lymph node metastases (P=.001) and the number of metastatic lymph nodes (P<.001). A significant correlation was detected between tumor cell VEGF-D expression and lymph node status (P=.001) and density of lymphatic vessel endothelial receptor (LYVE)-1-positive vessels (P=.035). VEGFR-3+/VEGF-D+ and VEGFR-3+/VEGF-C+ tumors had a significantly higher number of metastatic lymph nodes than tumors with other staining patterns (P<.001). Tumors positive for neither VEGF-D nor VEGFR-3 had a lower density of LYVE-1+ vessels than tumors with other staining patterns (P=.033). Our results indicate that peritumoral lymph vessel density is associated with lymph node metastases in invasive lobular breast cancer and that invasive lobular cancer producing VEGF-D, surrounded by VEGFR-3+ vessels, has a significantly higher peritumoral lymph vessel density and a higher number of metastatic lymph nodes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor D,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-9173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
128
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
759-66
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17951197-Breast Neoplasms,
pubmed-meshheading:17951197-Carcinoma, Lobular,
pubmed-meshheading:17951197-Endothelial Cells,
pubmed-meshheading:17951197-Female,
pubmed-meshheading:17951197-Humans,
pubmed-meshheading:17951197-Lymph Nodes,
pubmed-meshheading:17951197-Lymphatic Metastasis,
pubmed-meshheading:17951197-Middle Aged,
pubmed-meshheading:17951197-Neoplasm Proteins,
pubmed-meshheading:17951197-Neoplasm Staging,
pubmed-meshheading:17951197-Tumor Markers, Biological,
pubmed-meshheading:17951197-Vascular Endothelial Growth Factor D,
pubmed-meshheading:17951197-Vascular Endothelial Growth Factor Receptor-3
|
pubmed:year |
2007
|
pubmed:articleTitle |
VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
|
pubmed:affiliation |
Breast Surgery Unit, Department of Oncology, Helsinki University Hospital, Helsinki, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|